Mesoblast Limited
MESO · NASDAQ
Το Bulios Scoring περιγράφει την ποιότητα και το ιστορικό μιας εταιρείας, όχι τη μελλοντική απόδοση. Ένα υψηλό σκορ δεν είναι σήμα αγοράς. Μάθετε περισσότερα
Σχετικά με την εταιρεία
Mesoblast Limited is an Australian biopharmaceutical company specializing in the development and commercialization of regenerative therapeutic products for the treatment of various diseases. The company focuses on using cell therapy and biological drugs to regenerate and repair tissues. Their main product portfolio includes therapeutic products for the treatment of bone and joint diseases, heart diseases, skin diseases, and autoimmune disorders. Mesoblast boasts a range of clinical studies and research projects exploring the potential of their therapeutic products in various indications. The company is known for its expertise in the field of cell therapy and regenerative medicine. Mesoblast Limited shares could be an interesting choice for investors looking for opportunities in biotechnology and regenerative medicine treatment.
Δεν είναι ακόμη διαθέσιμο στη γλώσσα σας, επομένως το κείμενο είναι στα αγγλικά.
Sector
Healthcare
Industry
Biotechnology
CEO
Silviu Itescu
Employees
108
Headquarters
Melbourne
Επερχόμενα γεγονότα
Earnings
Upcoming earnings report